Alembic Pharma (APLLTD)
FAST GROWERFairStock Score: 52/100 — MIXED
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹769.8 |
| Market Cap | ₹13,979.57 Cr |
| P/E Ratio | 21.07 |
| ROCE | 13.05% |
| ROE | 12.12% |
| Dividend Yield | 1.55% |
| Profit Growth | 4% |
| Debt/Equity | 0.28 |
| Sales Growth | 13.2% |
| Free Cash Flow | ₹-48,000 Cr |
| Promoter Holding | 69.74% |
| 52-Week Range | ₹635.8 — ₹1,107.9 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹264.09 |
Alembic Pharma trades with a P/E ratio of 21.07, ROCE of 13.05%, ROE of 12.12%, profit growth of 4%, debt-to-equity of 0.28. The FairStock Score of 52/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer